Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Phase II/Pilot Study of 2nd Generation Anti-CEA Esigner T Cells in Adenocarcinomas"

NCT01723306 is registered in ClinicalTrials.gov with Roger Williams Medical Center as lead sponsor.

NCT NCT01723306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01723306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Phase II/Pilot Study of 2nd Generation Anti-CEA Esigner T Cells in Adenocarcinomas"
Lead sponsor
Roger Williams Medical Center
Phase
Phase 2
Overall status
Suspended
Start date
October 31, 2012
Completion date
August 31, 2017
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancers